WHILYAS
Wound healing ILYA-style
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0WHILYAS project word cloud
Explore the words cloud of the WHILYAS project. It provides you a very rough idea of what is the project "WHILYAS" about.
Project "WHILYAS" data sheet
The following table provides information about the project.
| Coordinator |
ILYA PHARMA AB
Organization address contact info |
| Coordinator Country | Sweden [SE] |
| Project website | http://www.ilyapharma.se |
| Total cost | 2˙992˙575 € |
| EC max contribution | 2˙992˙575 € (100%) |
| Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
| Code Call | H2020-SMEINST-2-2016-2017 |
| Funding Scheme | SME-2 |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-03-01 to 2019-08-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | ILYA PHARMA AB | SE (UPPSALA) | coordinator | 2˙992˙575.00 |
Map
Project objective
The objective of the project is to develop the EV100 drug candidate to heal chronic wounds in patients with diabetes in a better, faster, and cheaper manner than any method available today. We have chosen to target wounds in patients with diabetes, due to a large unmet medical need in this group. Today, 18% of people with diabetes have a chronic wound which translates into at least 6 million people in Europe alone. One of the complications of diabetes, diabetic foot ulcers (DFUs) often result in limb amputation. The mortality rate after an amputation is 30% within the first year, which is similar to several cancers. Even more alarming, treatment is today limited to mechanical debridement, use of different dressings, and a substantial overuse of antibiotics. Industrialized countries spend 2-4% of total healthcare budget on chronic wounds. The market for wound care is EUR 15 billion and the segment of DFUs is in the range of EUR 1.5 billion, with 11% CAGR 2011-2014. We have designed and built genetically modified lactic acid bacteria that accelerate wound healing with a unique efficiency. Human therapeutic proteins endogenously involved in tissue regeneration are continuously delivered on site in wounds by the lactic acid bacteria that act like small local bioreactors. EV100 is one of the candidate drugs in our library using Ilya100TM technology and is Lactobacillus expressing the human chemokine CXCL12. The Lactobacillus are freeze-dried and revived with water just prior to topical administration. The innovation stems from world-leading medical research in immunophysiology and microbiology at Uppsala University and the Swedish University of Agricultural Sciences. With EV100 chronic wounds could possibly be healed approx. 66% faster, implying annual cost savings of EUR 6 billion in the US and Europe and tackling all the personal and social difficulties associated with chronic wounds, increasing the quality of life of patients all around the world.
Deliverables
| An updated plan for the exploitation and dissemination of the results | Documents, reports | 2020-02-11 12:59:43 |
| ORDP - Open Research Data Pilot | Open Research Data Pilot | 2020-02-11 12:59:43 |
Take a look to the deliverables list in detail: detailed list of WHILYAS deliverables.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2018 |
Evelina Vågesjö, Emelie Öhnstedt, Anneleen Mortier, Hava Lofton, Fredrik Huss, Paul Proost, Stefan Roos, Mia Phillipson Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria published pages: 1895-1900, ISSN: 0027-8424, DOI: 10.1073/pnas.1716580115 |
Proceedings of the National Academy of Sciences 115/8 | 2020-02-11 |
| 2019 |
Emelie Öhnstedt, Hava Lofton Tomenius, Evelina Vågesjö, Mia Phillipson The discovery and development of topical medicines forwound healing published pages: , ISSN: 1746-045X, DOI: |
Expert Opinion on Drug Discovery | 2020-02-11 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "WHILYAS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "WHILYAS" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.3.1.3.)
DIAdIC (2019)
Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial
Read More